Recruitment of trial participants through electronic medical record patient portal messaging: A pilot studyTimothy B. Plante, Lynne Hammann, Kelly T. Gleason et al.|Clinical Trials|2019Cited by 41
Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A. Gebo, David Sullivan, Oliver Laeyendecker et al.|mBio|2023Cited by 22
Early Treatment, Inflammation and Post-COVID ConditionsKelly A. Gebo, David Sullivan, Sonya L. Heath et al.|medRxiv|2023Cited by 5
Erratum for Gebo et al., “Early antibody treatment, inflammation, and risk of post-COVID conditions”Kelly A. Gebo, David Sullivan, Sonya L. Heath et al.|mBio|2023Cited by 5
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody TherapyYuriko Fukuta, David Sullivan, Kelly A. Gebo et al.|Open Forum Infectious Diseases|2023Cited by 0